Archive for November, 2006
Cytos Biotechnology’s anti-obesity vaccine fails.
The anti-obesity vaccine from Cytos Biotechnology I blogged about on October 14, 2006 failed its Phase III clinical trials. Its CEO, Dr. Wolfgang Renner, remarked, “Based on the available data, a further development of this particular vaccine candidate in obesity is not warranted.”
The strange thing is the vaccine didn’t totally fail: it elicited strong antibody [...]
A radical, two-fold approach to weight loss.
In collaboration with prestigious Columbia University, Ambryx Biotechnology has new technology designed to:
Reduce the number of fat cells.
Prevent fat storage.
Turning Stem Cells into a Cancer vaccine
Using a mouse model, researchers John Eaton and Robert Mitchell at the University of Louiseville’s Brown Cancer Center have demonstrated that vaccinating mice with embryonic stem cells has the potential to prevent cancer in mice.
Read Full Post | Make a Comment ( 3 so far )“Life-extending” sirtuins in the news again
I blogged on this some time ago, but a recent Harvard Medical School study reaffirms and expounds on some fascinating insight into how sirtruins work to prevent–and perhaps reverse–aging.
Read Full Post | Make a Comment ( 2 so far )
